TempraMed signs LOI for exclusive Greece distribution of VIVI products
TempraMed Technologies Ltd. signed a letter of intent with CPO Greece for an exclusive distribution framework covering TempraMed’s injectable medication-protection products across Greece, linked to VIVI products.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.